Towards a Structural Basis of Complex Disorders of Heart, Muscle and Brain

Date & Time

About Simons Foundation Lectures

Simons Foundation Lectures are free public colloquia related to basic science and mathematics. These high-level talks are intended for professors, students, postdocs and business professionals, but interested people from the metropolitan area are welcome as well.
Video Thumbnail

By clicking to watch this video, you agree to our privacy policy.

Ryanodine receptors (RyR) are intracellular calcium-release channels found in almost all cell types. Andrew Marks and his team recently solved the high-resolution structure of the skeletal muscle form, RyR1. The structure provides insight regarding how dysfunctional RyR channels contribute to common diseases, including heart failure, muscular dystrophy and Alzheimer’s disease.

In this lecture, Dr. Marks will present new data on the high-resolution structure of the mammalian RyR1/intracellular calcium-release channel obtained using cryogenic electron-microscopy. Chronic stress mediated by oxidation and phosphorylation of the channel render it ‘leaky.’ This results in a pathological intracellular calcium leak from the sarcoplasmic/endoplasmic reticuli. This intracellular calcium leak causes distinct pathologies in different tissues. In cardiac muscle, RyR leak contributes to heart failure and cardiac arrhythmias. In skeletal muscle, RyR leak contributes to muscle weakness in muscular dystrophies and cancer metastatic to bone. In the brain, leaky RyR channels contribute to cognitive dysfunction in post-traumatic stress disorder and Alzheimer’s disease.

About the Speaker

Andrew R. Marks, M.D. is chair and professor of physiology and cellular biophysics at Columbia University. He discovered that ‘leaky’ intracellular calcium-release channels (ryanodine receptors, or RyR) contribute to heart failure, cardiac arrhythmias, impaired exercise capacity, post-traumatic stress disorder and Alzheimer’s disease. He developed a new class of small molecules (Rycals) targeting leaky RyR. Rycals are in clinical trials for heart failure, cardiac arrhythmias, and Duchenne muscular dystrophy.

Advancing Research in Basic Science and MathematicsSubscribe to our newsletters to receive news & updates